Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2009-4-24
pubmed:abstractText
It was reported previously that 30 min administration of adrenomedullin (AM) improves hemodynamics in chronic stable heart failure patients. The present study was designed to examine whether long-term AM + human atrial natriuretic peptide (hANP) administration can be used as a therapeutic drug in patients with acute decompensated heart failure (ADHF) in clinical setting.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1346-9843
pubmed:author
pubmed:issnType
Print
pubmed:volume
73
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
892-8
pubmed:meshHeading
pubmed-meshheading:19346663-Acute Disease, pubmed-meshheading:19346663-Adrenomedullin, pubmed-meshheading:19346663-Aged, pubmed-meshheading:19346663-Atrial Natriuretic Factor, pubmed-meshheading:19346663-Biological Markers, pubmed-meshheading:19346663-Cardiovascular Agents, pubmed-meshheading:19346663-Drug Administration Schedule, pubmed-meshheading:19346663-Drug Therapy, Combination, pubmed-meshheading:19346663-Female, pubmed-meshheading:19346663-Heart Failure, pubmed-meshheading:19346663-Hemodynamics, pubmed-meshheading:19346663-Humans, pubmed-meshheading:19346663-Infusions, Intravenous, pubmed-meshheading:19346663-Kidney, pubmed-meshheading:19346663-Male, pubmed-meshheading:19346663-Oxidative Stress, pubmed-meshheading:19346663-Pilot Projects, pubmed-meshheading:19346663-Time Factors, pubmed-meshheading:19346663-Treatment Outcome, pubmed-meshheading:19346663-Urodynamics
pubmed:year
2009
pubmed:articleTitle
Effects of long-term intravenous administration of adrenomedullin (AM) plus hANP therapy in acute decompensated heart failure: a pilot study.
pubmed:affiliation
Department of Hypertension and Cardiorenal Medicine, Dokkyo Medical University, Mibu, Japan. nishikim@dokkyomed.ac.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't